CSSi LifeSciences has developed this Survival Guide to help you maximize the number of meetings scheduled with investors and strategic licensing partners attending the J.P. Morgan Healthcare Conferences and thereby increase your opportunities for success.
Learn effective strategies to expedite your IND-enabling studies. Discover how to efficiently and effectively streamline and schedule preclinical studies to meet your regulatory submission milestone.
CSSi LifeSciences has developed this Survival Guide to help you maximize the number of meetings scheduled with investors and strategic licensing partners attending the J.P. Morgan Healthcare Conferences and thereby increase your opportunities for success.
Andrzej Zylicz, Hired as Vice President Business Development North America & Equity Partner
Bowers R&D Associates is thrilled to announce that it is now offering R&D tax credit calculation services nationwide. Client Relationship Manager Laura Berry and Sales Administrator Marsha Cook are eager to meet with clients across the country to help them get the R&D credits they deserve.
Several Johnson & Johnson Innovation – JLABS (JLABS) @ Washington, DC resident companies had the opportunity to meet and greet and make presentations at the 2023 BLUE KNIGHT™ Symposium and BIO International Convention during the beginning of June. The Blue Knight Symposium is part of Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), within the U.S. Department of Health and Human Services. Hosted in association with the 2023 BIO International Convention, the Symposium was held in Boston from June 5-8, 2023.
As one of the only new, Class A life science buildings delivering in 2023, Monument Innovation Center offers space to meet the demands and specific needs of a variety of scientific disciplines, from research and development to biotechnology and environmental sciences. Ideally located in Maryland’s leading life science corridor proximate to Washington D.C., it is in a prestigious cluster of established and emerging life science companies with access to top academic institutions, government agencies, and Montgomery County’s highly educated workforce.
Choosing the Right Preclinical CRO for Cell and Gene Therapy Product Development: Tips from Noble Life Sciences June 14, 2023 You have an exciting asset at your disposal, and after [….]
These Four Leading CROs in Maryland are Driving Success in Life Sciences By Alex KeownJune 8, 2023 This article is sponsored by Noble Life Sciences, a Maryland-based preclinical CRO with [….]
FITCI Opens Applications for EDGE Accelerator Cohort By Alex KeownJune 5, 2023 The Frederick Innovative Technology Center, Inc. (FITCI) is accepting applications for the 2023 cohort of its EDGE Accelerator [….]
